Gregory Madison

Gregory Madison

Corporate Officer/Principal en PROKIDNEY CORP. .
59 años
Health Technology
Health Services
Consumer Services

Perfil

Gregory Paul Madison is currently Director at Phosphate Therapeutics Ltd. since 2021, Trustee at American Kidney Fund, Inc., and Chief Commercial Officer at ProKidney Corp.
starting in 2026.
Former roles include President, Chief Executive Officer & Director at Keryx Biopharmaceuticals, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at Melt Pharmaceuticals, Inc.; Group Chief Executive Officer & Director at Shield Therapeutics Plc from 2021 to 2024; Director at Kidney Care Partners; Vice President & General Manager-Nephrology at Genzyme Corp.
from 2000 to 2012; and Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2013 to 2014.
Education includes undergraduate studies at the University of Massachusetts.

Cargos activos de Gregory Madison

EmpresasCargoInicio
PROKIDNEY CORP. Corporate Officer/Principal 25/03/2026
Director/Miembro de la Junta -
Director/Miembro de la Junta 18/06/2021

Antiguos cargos conocidos de Gregory Madison.

EmpresasCargoFin
SHIELD THERAPEUTICS PLC Director Ejecutivo 24/07/2024
KERYX BIOPHARMACEUTICALS Director Ejecutivo 30/04/2018
Director/Miembro de la Junta 30/09/2014
AMAG PHARMACEUTICALS, INC. Corporate Officer/Principal 07/02/2014
Corporate Officer/Principal 01/01/2012
Ver el detalle de la experiencia de Gregory Madison.

Formación de Gregory Madison.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

89

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN